Technical Field

[01] The present disclosure relates to silane compounds that include functional groups that can be useful for polymerization, chain transfer, or as a curative agent.

Summary

[02] A compound according to formula I:

X-(CF ₂ ) _n -(0) _p -(CH ₂ ) _m -Si-Y ₃ (I) wherein X is CF ₂ =CF-0-, CH ₂ =CHCH ₂ -0-, or CH ₂ =CHCH ₂ -; n is an integer from 2 to 8; m is an integer from 2 to 5; p is 0 or 1; and Y is Cl- or -OR, where R is a linear or branched alkyl having 1 to 4 carbon atoms. In some embodiments, Y is -0(CH ₂ ) _x CFl3, where x is an integer from 0 to 3.

[03] The above summary is not intended to describe each embodiment of the present disclosure. The details of one or more embodiments of the present disclosure are also set forth in the description below. Other features, objects, and advantages of the present disclosure will be apparent from the description and from the claims.

Detailed Description

[04] Fluorochemicals having a functional group can be useful as intermediates in a wide variety of applications. Their usefulness may be due to properties they can impart, including for example thermal resistance, chemical resistance, or both; oleophobicity, hydrophobicity, or both; or combinations thereof.

[05] Silanes can be useful as crosslinking agents to crosslink polymers thereby improving tear

resistance, elongation at break, abrasion resistance, or combinations thereof. Silane coupling agents bind to minerals or silica type fillers resulting in improvements in mixing, bonding of fillers to polymers, matrix strength, or combinations thereof. Silanes can also adhere fibers such as glass fibers, carbon fibers, or both to certain polymers to make the matrix compatible.

Additional applications include water repellency, usefulness in adhesives to repel water, masonry protection, graffiti control and as sealants.

[06] Disclosed herein are compounds including a silane group, a fluorinated group and a functional group. The silane group and the fluorinated group provide advantageous properties and the functional group provides chemical functionality to disclosed compounds. For example, the functional group can be chosen such that the compound can function as a chain-transfer agent, the compound can function as a curative, or some combination thereof.

[07] In some embodiments, one method of making such disclosed compounds includes bonding a compound having a functional end with fluorinated carbons followed by an alkene on the opposite end that has been hydrosilylated with trichlorosilane using a platinum catalyst. This synthetic method is illustrated by the generic Scheme 1 below.

X-(CF ₂ ) _n -(0) _p -(CH ₂ ) _m -CH=CH ₂ + HS1CI3 (Pt) ®· X-(CF ₂ ) _n -(0) _p -(CH ₂ ) _m -Si-Cl ₃

Scheme 1

In Scheme 1, X can be selected from CF ₂ =CF-0-, CH ₂ =CHCH ₂ -0-, or CH ₂ =CHCH ₂ -; n can be an integer from 2 to 8; m can be an integer from 2 to 5; p is 0 or 1; and Y is Cl- or -OR, where R is a linear or branched alkyl having 1 to 4 carbon atoms. In some embodiments, Y is - 0(CH ₂ ) _X CH3, where x is an integer from 0 to 3. Scheme 2 presents a more specific illustration of this particular synthetic method, wherein p = 0.

X-(CF ₂ ) _n -(CH ₂ ) _m -CH=CH ₂ + HS1CI3 (Pt) ®· X-(CF ₂ ) _n -(CH ₂ ) _m -Si-Cl ₃

Scheme 2

[08] In some methods, the trichlorosilane compounds can be reacted with an alcohol to produce easier to handle trialkoxy silanes. This synthetic method is illustrated by the generic Scheme 3 below using a linear alcohol as an exemplary alcohol.

X-(CF ₂ ) _n -(0)p-(CH ₂ ) _m -Si-( 0(CH ₂ ) _x CH ₃ ) ₃ Scheme 3

In Scheme 3, X, m, n, and p are as defined above. Scheme 4 presents a more specific illustration of this particular synthetic method, wherein p = 0.

Scheme 4

[09] Disclosed compounds include those of formula I below. X-(CF ₂ ) _n -(0) _p -(CH ₂ ) _m -Si-Y ₃ (I)

[010] X can be selected from CF ₂ =CF-0-, CH ₂ =CHCH ₂ -0-, or CH ₂ =CHCH ₂ -; n can be an integer from 2 to 8; m can be an integer from 2 to 5; p is 0 or 1; and Y can be Cl- or -OR, where R is a linear or branched alkyl having 1 to 4 carbon atoms. In some embodiments, Y is -0(CH ₂ ) _X CH3, where x is an integer from 0 to 3. In some embodiments, n can be an integer from 2 to 7, from 2 to 6 or even from 2 to 4. In some embodiments, m can be an integer from 2 to 4 or from 2 to 3.

In some embodiments, Y can be -0(CH ₂ ) _X CH3 where x is 0, i.e., where Y is -OCH3.

[Oi l] Illustrative specific compounds disclosed herein include:

CF ₂ =CF-0-C ₄ F ₈ -CH ₂ CH ₂ -SiCl ₃ (MV4ETCS),

CF2=CF-0-C ₄ F ₈ -CH ₂ CH ₂ -Si(0CH ₃ ) ₃ (MV4ETMS),

CF ₂ =CF-0-C ₄ F ₈ -CH ₂ CH ₂ CH ₂ -SiCl ₃ (MV4PTCS),

CF =CF-0-C ₄ F ₈ -CH CH ₂ CH -Si(0CH ₃ )3 (MY4PTMS),

CH ₂ =CHCH ₂ C ₄ F ₈ CH ₂ CH ₂ CH ₂ SiCl ₃ (AC4PTCS),

CH ₂ =CHCH ₂ C ₄ F ₈ CH ₂ CH ₂ CH ₂ Si(OCH ₃ ) ₃ (AC4PTM),

CH2=CHCH2-0-C4F ₈ -0-CH ₂ CH ₂ CH ₂ SiCl ₃ (AEC4EPTCS), and

CH ₂ =CHCH ₂ -0-C F ₈ -0-CH ₂ CH ₂ CH ₂ Si(0CH ₃ ) ₃ (AEC4EPTMS).

Other exemplary compounds include trialkoxy silane analogues of such trimethoxy silanes, e g., triethoxy silanes.

[012] All scientific and technical terms used herein have meanings commonly used in the art unless otherwise specified. The definitions provided herein are to facilitate understanding of certain terms used frequently herein and are not meant to limit the scope of the present disclosure.

[013] As used in this specification and the appended claims, the singular forms“a”,“an”, and“the” encompass embodiments having plural referents, unless the content clearly dictates otherwise.

[014] As used in this specification and the appended claims, the term“or” is generally employed in its sense including“and/or” unless the content clearly dictates otherwise. The term“and/or” means one or all of the listed elements or a combination of any two or more of the listed elements.

[015] As used herein,“have”,“having”,“include”,“including” ,“comprise”,“comprising” or the like are used in their open-ended sense, and generally mean“including, but not limited to”. It will be understood that“consisting essentially of’,“consisting of’, and the like are subsumed in “comprising” and the like. For example, a composition that“comprises” silver may be a composition that“consists of’ silver or that“consists essentially of’ silver. [016] As used herein,“consisting essentially of,” as it relates to a composition, apparatus, system, method or the like, means that the components of the composition, apparatus, system, method or the like are limited to the enumerated components and any other components that do not materially affect the basic and novel characteristic(s) of the composition, apparatus, system, method or the like.

[017] The words“preferred” and“preferably” refer to embodiments that may afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the disclosure, including the claims.

[018] Also herein, the recitations of numerical ranges by endpoints include all numbers subsumed within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, 5, etc. or 10 or less includes 10, 9.4, 7.6, 5, 4.3, 2.9, 1.62, 0.3, etc.). Where a range of values is“up to” a particular value, that value is included within the range.

[019] Use of“first,”“second,” etc. in the description above and the claims that follow is not intended to necessarily indicate that the enumerated number of objects is present. For example, a “second” substrate is merely intended to differentiate from another substrate (such as a“first” substrate). Use of“first,”“second,” etc. in the description above and the claims that follow is also not necessarily intended to indicate that one comes earlier in time than the other.

[020] While particular implementations of functional fluorinated silane compounds are described

herein, other configurations and embodiments consistent with and within the scope of the present disclosure will be apparent to one of skill in the art upon reading the present disclosure. Various modifications and alterations of the present disclosure will become apparent to those skilled in the art without departing from the scope and spirit of this invention.

[021] Examples

[022] Objects and advantages may be further illustrated by the following examples, but the particular materials and amounts thereof recited in these examples, as well as other conditions and details, should not be construed to unduly limit this disclosure.

[023] All materials are commercially available, for example from Sigma-Aldrich Chemical Company, Milwaukee, WI, USA, or known to those skilled in the art, unless otherwise stated or apparent. Unless otherwise noted, all parts, percentages, ratios, etc. in the examples and the rest of the specification are by weight. The following abbreviations are used in this section: mL=milliliters, g=grams, lb=pounds, mm=millimeters, wt%= percent by weight, min=minutes, h=hours, NMR=nuclear magnetic resonance, ppm=parts per million, phr = parts per hundred rubber; °C = degrees Celsius, dNm = deci-newton-meter, mmHg = millimeters of mercury, kPa = kilopascal, mol = moles, psig = pounds per square inch gauge Abbreviations for materials used in this section, as well as descriptions of the materials, are provided in Table 1.

Table 1

[024] Example 1. Preparation of CF2=CF-0-C4F ₈ -CH ₂ CH ₂ -SiCl3, MV4ETCS

[025] To a 40 ml heavy wall glass ampoule having a threaded top containing a magnetic stir bar was charged with 12g, 0.04mol of CF ₂ =CF-0-C ₄ F ₈ -CH=CH ₂ described in W02014200973 as MV4E and 5.4g, 0.04mol of HS1CI3 available from Aldrich. The mixture was stirred and lOOuL of a 2.4 weight % Pt as platinum-divinyltetramethyl disiloxane complex available from Gelest, Inc. was added. The glass ampoule was sealed by a glass tube inserted into the top by a threaded plastic cap and O-ring. The reaction was run at l00°C for 20 hours. Vacuum distillation isolated 8.8g, 0.02mol of CF ₂ =CF-0-C ₄ F ₈ -CH ₂ CH ₂ -SiCl3 boiling of 60°C at 3mm for a 52% yield. NMR confirmed the compound. [026] Example 2. Preparation of CF2=CF-0-C ₄ F ₈ -CH2CH2-Si(0CH ₃ )3, MV4ETMS

[027] To a 250ml 3-neck round bottom flask containing a magnetic stir bar, thermocouple and

condenser was charged with 5g excess methanol available from Aldrich. The methanol was stirred and 7g, 0.0l3mol of compound from example 1 was added drop wise. The reaction was stirred at 25 °C for 15 minutes and vacuum distillation isolated 5.4g, 0.0l2mol of CF2=CF-0-

C4Fg-CFl2CF[2-Si(OCFl3)3 boiling of 52 °C at 2 mm for an 83% yield. l^FNMR negative upfield of internal CFCI3, ' HNMR ppm downfield of internal TMS and ^SiNMR negative ppm upfield of internal TMS in CDCI3.

[028] -Sij(0CH3 ^k )3, (a) -122.4 d/d/t (112.3 Hz d,

85.2 Hz d, 5.9 Hz t), (b) -114.5 d/d (85.2 Hz d, 65.8 Hz d), (c) -135.5 d/d/t (112.3 Hz d, 65.8 Hz d, 5.8 Hz t), (d) -85.4 m (5.8 Hz m), (e) -125.4 m, (f) -124.0 m. (g) -117.2 m, (h) 2.18 m, (i) 0.87 m, (k) 3.61 s, 0 -44.2.

[029] Example 3. Preparation of CF2=CF-0-C ₄ F ₈ -CH ₂ CH2CH2-SiCl3, MV4PTCS

[030] The compound CF2=CF-0-C ₄ F ₈ -CH2CH=CH2 was made as described in W02014200973 as ClCF2CFCl-0-C ₄ F ₈ -SC>2Na and reacted first by addition of 375g, 0.82mol into a 3L 3-neck round bottom equipped with a mechanical stirrer, thermocouple and condenser and containing 1L dimethylformamide, l50g, l .24mol allyl bromide and 220g, 0.92mol of sodium

peroxydi sulfate all available from Alfa Aesar. The stirred mixture was heated to 45°C and addition of the di chloride over one hour the temperature reached 1 l5°C. The mixture was cooled to 25°C and washed three times with 500g of distilled water. Vacuum distillation gave l80g of ClCF ₂ CFCl-0-C ₄ F ₈ -CH ₂ CH=CH2 boiling at 70-82°C at 5mm for a 53% yield.

Dechlorinated was done in a 1L 3 -neck round bottom flask equipped with a mechanical stirrer, thermocouple and condenser and containing 300ml dimethylformamide, 58g, 0.88mol zinc powder and 0. lg bromine all available from Alfa Aesar. The mixture was stirred and heated to 95 °C and 180g, 0.44mol ClCF2CFCl-0-C ₄ F ₈ -CH2CH=CH2 was added over one hour with the temperature reaching 1 l4°C. The product and dimethylformamide was atmospherically codistilled cooled to 25°C and water washed twice with 500g of distilled water. Distillation gave 87g CF2=CF-0-C ₄ F ₈ -CH2CH=CH2 boiling at l28°C for a 59% yield. To a 40 ml heavy wall glass ampoule having a threaded top containing a magnetic stir bar was charged with l2g, 0.036mol of CF2=CF-0-C ₄ F ₈ -CH2CH=CH2 and 5.4g, 0.04mol of HS1CI3 available from Aldrich. The mixture was stirred and lOOuL of a 2.4 weight % Pt as platinum-divinyltetramethyl disiloxane complex available from Gelest, Inc. was added. The glass ampoule was sealed by a glass tube inserted into the top by a threaded plastic cap and O-ring. The reaction was run at l30°C for 20 hours. Vacuum distillation isolated 1 l.5g, 0.024mol of CF2=CF-0-C4F ₈ -

CH2CH2CH2-SiCl3 boiling of 74 °C at 3mm for a 68% yield. l^FNMR negative upfield of internal CFCI3, ' HN R ppm downfield of internal TMS and 29gj \,fR negative ppm upfield of internal TMS in CDCI3.

[031] -122.3 d/d/t (112 Hz d, 84.7 Hz d, 5.8 Hz t), (b) -114.2 d/d (84.7 Hz d, 66.0 Hz d), (c) -135.5 d/d/t (112 Hz d, 66.0 Hz d, 6.1 Hz t), (d) -85.5 m, (e) -125.5 m, (f) -124.3 m, (g) -115.0 m, (h) 2.18 t/t (17.9 Hz t, 8.0 Hz t), (i) 1.94 m (8.0 Hz m), (j) 1.49 m, (k) -11.5.

[032] Example 4. Preparation of CF ₂ =CF-0-C4F ₈ -CH2CH ₂ CH2-Si(0CH3)3, MV4PTMS

[033] To a 250ml 3-neck round bottom flask containing a magnetic stir bar, thermocouple and

condenser was charged with 1 lg excess methanol available from Aldrich. The methanol was stirred and 22g, 0.046mol of compound from example 3 was added drop wise. The reaction was stirred at 25°C for 15 minutes and vacuum distillation isolated l9g, 0.04mol of CF2=CF-0- C4F ₈ -CH2CH2CH2-Si(OCH3)3 boiling of 83°C at 2 mm for an 90% yield. NMR confirmed the compound.

[034] Example 5. Preparation of CH2=CHCH2C4F ₈ CH2CH2CH ₂ SiCl ₃ , AC4PTCS

[035] To a 1 L, 3-neck round bottom flask equipped with a mechanical stirrer, thermocouple and

condenser was charged 454 g (1.0 mol) of IC4F ₈ I, 300 g (3.0 mol) of allyl acetate and 4 g (0.018 mol) of t-butylperoxy-2-ethylhexanoate. The mixture was stirred and heated to 75 °C for 20 h. The red-brown solution was vacuum stripped to remove starting allyl acetate and added dropwise to a 1 L, 3-neck round bottom flask equipped with a mechanical stirrer, thermocouple and condenser that was charged with 125 g (1.9 mol) of zinc powder, 400 g methanol that was activated with 10 g (0.06 mol) of bromine. The mixture was allowed to reflux at 65 °C for 1 h and distilled over into a receiver containing water to isolate 105 g (0.37 mol) of diallyl octafluorobutane. To a 250 mL, round bottom flask equipped with a mechanical stirrer, thermocouple and condenser was charged 105 g (0.37 mol) of diallyl octafluorobutane, 20g (0.15 mol) of trichlorosilane and 300 ppm platinum divinyl tetramethyl disiloxane complexstirred and heated to 60 °C for 4 h. The solution was vacuum stripped to first remove excess diallyl octafluorobutane, isolating 78 g (0.19 mol) of CF^CHCF^C^FgCFhCF^CF^SiCb, having a boiling point of 66 °C at 5 Torr for a 73% yield. NMR confirmed the compound.

[036] Example 6. Preparation of CH ₂ =CHCH2C4F ₈ CH2CH2CH ₂ Si(OCH3)3, AC4PTMS

To a 250 mL 3-neck, round bottom flask containing a magnetic stir bar, thermocouple and condenser was charged 25 g methanol. The methanol was stirred and 45g (0.11 mol) of compound from example 5 was added dropwise. The reaction was stirred at 30 °C for 15 min and vacuum distillation isolated 38g (0.09 mol) of CF^CHCFbC^FgCF^CFLCF^SilOCH l having a boiling point of 95 °C at 2 Torr for an 87% yield. NMR confirmed the compound. l^F MR negative upfield of internal CFCI3, * HNMR ppm downfield of internal TMS and 29si MR negative ppm upfield of internal TMS in CDCI3.

CHaHb=CHCCH2 ^d CF2 ^e CF2 ^f CF2gCF2 ^h CH2 ⁱ CH ₂ jCH2 ^k Si ¹ (OCH3 ^m )3, ( _a ) 5.31 d/d (8.3 Hz d, l.2 Hz d), (b) 5.30 d/d (9.3 Hz d, 1.2 Hz d), (c) 5.81 d/d/t (18.3 Hz d, 9.3 Hz d, 7.0 Hz t), (d)

2.83 t/d, (e) -113.7 m (18.4 Hz m), (f) -123.6 m, (g) -124.0 m, (h) -114.9 m, (i) 2.11 t/t, (j) 1.76 m, (k) 0.716 t, (1) -43.3, (m) 3.58 s.

[037] Example 7. Preparation of CH2=CHCH ₂ -0-C4F ₈ -0-CH2CH2CH ₂ SiCl3, AEC4EPTCS

[038] To a 600 mL stirred reactor, available from Parr Instrument Company, was charged 100 g (1.7 mol) KF, 12 g (0.04 mol) tetra-n-butylammonium bromide, and 250 g diglyme. The reactor was sealed and placed under 25 Torr of vacuum. To the reactor was charged 121 g (1.0 mol) allylbromide, available from TCI, and 70 g (0.36 mol) perfluorosuccinyl fluoride, after the reactor was cooled to 6 °C. The contents of the reactor were stirred and heated to 75 °C for 20 h. The reactor was cooled to 25 °C and the contents were washed three times each with 400 g distilled water. Distillation of the lower fluorochemical phase gave 67 g (0.21 mol)

octafluorobutane diallyl ether, CH2=CHCH2-0-C4F ₈ -0-CH2CH=CH2, with a boiling point of

35 °C at 3 Torr for a 59% yield. Two additional runs were carried out and the products of the three runs were combined to yield a total of 200 g of octafluorobutane diallyl ether. In a 250 mL round bottom flask equipped with a stir bar was added 160 g (0.51 mol) octafluorobutane diallyl ether and 28 g (0.21 mol) of trichlorosilane, and 300 ppm platinum divinyl tetramethyl disiloxane complex. The contents were stirred and heated to 63 °C for 2 h. The solution was vacuum stripped to first remove excess octafluorobutane diallyl ether, resulting in isolation of 77 g (0.17 mol) of CH2=CHCH2-0-C4F ₈ -0-CH2CH2CH2SiCl3, having a boiling point of 92 °C at 3 Torr for a 82% yield. NMR confirmed the compound. [039] Example 8. Preparation of CH2=CHCH ₂ -0-C ₄ F ₈ -0-CH2CH2CH2Si(0CH3)3, AEC4EPTMS [040] To a 250 mL 3-neck, round bottom flask containing a magnetic stir bar, thermocouple and

condenser was charged 20 g methanol. The methanol was stirred and 22 g (0.05 mol) of compound from example 7 was added dropwise. The reaction was stirred at 30 °C for 15 min and vacuum distillation isolated 18 g, (0.04 mol) of CH2=CHCH2-0-C4F ₈ -0-

CH2CH2CH2Si(OCH3)3 having a boiling point of 82 °C at 3 Torr for an 86% yield. ^FNMR negative upfield of internal CFC13, ' HNMR ppm downfield of internal TMS and 29$jNMR negative ppm upfield of internal TMS in CDC1 _3. CH ^a H ^b =CH ^c CH2 ^d -0-CF ₂ ^e CF2 ^f CF28CF ₂ ^h - CH2 ⁱ CH ₂ jCH2 ^k Si ¹ (OCH ₃ ^m )3 _, (a) 5.38 d/m (17.4 Hz d), (b) 5.28 d/m (10.6 Hz d, 5.7 Hz m), (c) 5.91 d/d/t (10.6 Hz d, 12.4 Hz d, 5.7 Hz t), (d) 4.5 d/m (5.7 Hz d), (e) -85.9 m, (f) -125.8 m, (g) - 125.8 m, (h) -85.9 m, (i) 4.01 t (6.4 Hz t), (j) 1.82 m (6.4 Hz m), (k) 0.71 m, (1) -42.7, (m) 3.58 s.

[041] Thus, embodiments of functional fluorinated silane compounds are disclosed. The

implementations described above and other implementations are within the scope of the following claims. One skilled in the art will appreciate that the present disclosure can be practiced with embodiments other than those disclosed. The disclosed embodiments are presented for purposes of illustration and not limitation.